Wellington Management Group
AMRX icon

Wellington Management Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Wellington Management Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$965K Sell
55,772
-6,693
-11% -$91.7K ﹤0.01% 1751
2026
Q1 		$776K Sell
62,465
-1,696
-3% -$22.8K ﹤0.01% 1720
2025
Q4 		$808K Sell
64,161
-1,916
-3% -$21.9K ﹤0.01% 1755
2025
Q3 		$661K Buy
66,077
+460
+0.7% +$4.13K ﹤0.01% 1851
2025
Q2 		$531K Sell
65,617
-4,435
-6% -$33.4K ﹤0.01% 1814
2025
Q1 		$587K Sell
70,052
-3,967
-5% -$33.1K ﹤0.01% 1801
2024
Q4 		$586K Sell
74,019
-8,577
-10% -$72K ﹤0.01% 1808
2024
Q3 		$687K Buy
+82,596
New +$646K ﹤0.01% 1774
2022
Q2 		– Sell
-29,537
Closed -$123K – 2068
2022
Q1 		$123K Sell
29,537
-26,390
-47% -$117K ﹤0.01% 2084
2021
Q4 		$268K Hold
55,927
– – ﹤0.01% 2097
2021
Q3 		$299K Hold
55,927
– – ﹤0.01% 2045
2021
Q2 		$286K Buy
55,927
+1,185
+2% +$6.74K ﹤0.01% 2037
2021
Q1 		$369K Sell
54,742
-13,851,674
-100% -$76.8M ﹤0.01% 1927
2020
Q4 		$63.6M Sell
13,906,416
-1,504,609
-10% -$6.67M 0.01% 700
2020
Q3 		$59.8M Buy
15,411,025
+71,569
+0.5% +$306K 0.01% 653
2020
Q2 		$73M Buy
15,339,456
+15,607
+0.1% +$64.3K 0.02% 591
2020
Q1 		$53.3M Sell
15,323,849
-203,603
-1% -$862K 0.01% 620
2019
Q4 		$74.8M Sell
15,527,452
-364,937
-2% -$1.27M 0.02% 654
2019
Q3 		$46.1M Buy
15,892,389
+1,531,388
+11% +$5.34M 0.01% 739
2019
Q2 		$103M Sell
14,361,001
-1,546,279
-10% -$15.8M 0.02% 557
2019
Q1 		$225M Sell
15,907,280
-115,253
-0.7% -$1.52M 0.05% 336
2018
Q4 		$217M Buy
16,022,533
+4,821,681
+43% +$86.9M 0.05% 315
2018
Q3 		$249M Buy
11,200,852
+301,606
+3% +$6.35M 0.05% 335
2018
Q2 		$179M Buy
+10,899,246
New +$191M 0.04% 403

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group's AMRX Position: Q2 2026 in Review

Wellington Management Group reduced its Amneal Pharmaceuticals (AMRX) stake by 11% in Q2 2026, selling an estimated $91.7K and leaving 55,772 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Wellington Management Group first reported a position in AMRX in Q2 2018 and has held it in 24 quarters since. The position peaked at $249M in Q3 2018. 308 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Wellington Management Group held 55,772 shares of Amneal Pharmaceuticals worth $965K as of Q2 2026.
  • Wellington Management Group sold 6,693 Amneal Pharmaceuticals shares in Q2 2026, an estimated $91.7K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1751 holding.
  • Wellington Management Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
  • Wellington Management Group's Amneal Pharmaceuticals position peaked at $249M in Q3 2018.
  • 308 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.